Procedure to Treat Benign Prostatic Hyperplasia (BPH)
Benign prostatic hyperplasia, or BPH, is a non-cancerous condition that occurs when the prostate enlarges and constricts or obstructs urine flow. BPH affects nearly half of men over age 50 and approximately 80% of men in their 80s.
Baylor Scott & White – Temple offers a new, minimally invasive procedure called Holmium Laser Enucleation of the Prostate (HoLEP), which gives patients immediate improved urine flow in addition to long-term relief.
How Does HoLEP Work?
The HoLEP procedure uses a laser that targets the portion of the enlarged prostate that is affecting urine flow. The laser slices that portion into small, easily removable pieces.
- Ability to treat any size prostate gland with minimal bleeding
- A re-treatment rate of less than 2%
- Early, immediate relief of symptoms and fast return to normal activity. Patients usually go back to work within two to three days and can resume their physical exercise within two weeks
- Next-day catheter removal in most of the cases, with less than 24 hours hospital stay
- Minimal pain, requiring only oral pain control
- Fewer potential complications. The holmium laser technology offers a low-depth of penetration of less than half of 1 mm, which causes less damage to the underlying healthy tissue and lowers the risk for excessive bleeding